Depressive symptoms can define subgroups of
SAD
Heterogeneity has been identified in cases of SAD during both depressed and
non-depressed periods. It has been suggested that discriminant analysis of
symptoms may differentiate between types of patients with SAD.
Dr Namni Goel and colleagues from Columbia University in New York
investigated 165 depressed individuals with SAD to determine whether
different clinical profiles could differentiate between patients.
Patients with bipolar affective disorder (type I or II) or major depressive
disorder (MDD), both with seasonal variation, were included in the study,
which involved assessment using the Structure Interview Guide for the
Hamilton Depression Rating Scale – SAD version (SIGH-SAD).
Patients were categorised on the basis of bipolar or unipolar diagnosis,
non-depressed mood state, sex, race, menstrual status, eye colour, marital
and employment status.
The researchers found that bipolar patients had higher SIGH-SAD scores
generally, indicating greater severity of depression, and also had more
psychomotor agitation and social withdrawal compared to individuals with MDD.
Bipolar I patients had more severe psychomotor retardation, social
withdrawal and late insomnia than type II patients.
Differentiation was also possible between men and women with SAD, with men
showing more obsessive and compulsive symptoms and suicidality, and women
more weight gain and early insomnia.
Black patients were more likely to show hypochondriasis and social
withdrawal while whites had more guilt and fatiguability. Those with dark
eyes were more likely to be depressed and fatigued, while single patients
had more hypochondriasis and diurnal variation.
Atypical symptoms were more common among employed individuals than those who
were not working. In most cases, distinguishing items were included in the
Hamilton Depression Rating Scale.
The researchers conclude that the patients’ characteristics described here
may be used to differentiate subgroups of patients with SAD. They add that
the findings could be used to provide additional support for at-risk groups
in the community.
Source: Depression and Anxiety 2002
© Health Media Ltd 2002
http://www.health-news.co.uk